Assessment of amyloid β protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease

Journal of Neurochemistry

Volumn 66, Issue 1, 1996, Pages 259-265

  Southwick, Paula C ^a   Yamagata, Susan K ^a   Echols Jr , Charles L ^b   Higson, Gail J ^a   Neynaber, Scott A ^a   Parson, Robert E ^a   Munroe, William A ^a  

^a Hybritech Incorporated   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; CSF; Diagnosis

Indexed keywords

AMYLOID BETA PROTEIN; BIOCHEMICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID BRAIN LEVEL; ARTICLE; CEREBROSPINAL FLUID LEVEL; DEMENTIA; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0030071249     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66010259.x     Document Type: Article

References (26)

1. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., and Hyman B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
2. Barrow C. J. and Zagorski M. G. (1991) Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182.
3. Dovey H. F., Suomensaari-Chrysler S., Lieberburg I., Sinha S., and Keim P. S. (1993) Cells with a familial Alzheimer's disease mutation produce authentic β-peptide. Neuroreport 4, 1039-1042.
4. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122-1124.
5. Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., and Taylor J. O. (1989) Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262, 2551-2556.
6. Glenner G. G. and Wong C. W. (1984a) Alzheimer's disease; initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 122, 885-890.
7. Glenner G. G. and Wong C. W. (1984b) Alzheimer's disease and Down's syndrome; sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
8. Haass C., Hung A. Y., Selkoe D. J., and Teplow D. B. (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
9. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., and Beyreuther K. (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptide of Alzheimer's disease. J. Mol. Biol. 218, 149-163
10. Hyman B. T., Marzloff K., and Arriagada P. V. (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52, 594-600.
11. Kohler G. and Milstein C. (1975) Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 256, 495-497.
12. Lannfelt L., Basun H., Wahlund L.-O., Winblad B., Vigo-Pelfrey C., and Schenk D. (1994) Disease progression correlates with decreasing CSF β-amyloid in Alzheimer patients with the Swedish APP 670/671 mutation. Neurobiol. Aging 15 (Suppl.), 79.
13. Masters C. L., Simms G., Weidemann N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
15. Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K., and Iqbal K. (1993) Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 41-52.
16. Morris J. C., McKeel D. W. Jr., Fulling K., Torack R. M., and Berg L. (1988) Validation of clinical diagnostic criteria for Alzheimer's disease. Ann. Neurol. 24, 17-22.
17. Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T. T., Shaffer L. M., Golde T. E., Younkin L. H., Younkin S. G., and Hirai S. (1994) Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann. Neurol. 36, 903-911.
18. Oi V. T. and Herzenberg L. A. (1980) Immunoglobulin-producing hybrid cell lines, in Selective Methods in Cellular Immunology (Mishell B. B. and Shigii S. M., eds), pp. 351-372. Freeman and Co., San Francisco.
19. Roher A. E., Lowenson J. D., Clarke S., Wolkow C., Wang R., Cotter R. J., Reardon I. M., Zurcher-Neely H. A., Heinrikson R. L., Ball M. J., and Greenberg B. D. (1993) Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268, 3072-3083.
20. Selkoe D. J., Abraham C. R., Podlisny M. B., and Duffy L. K. (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820-1834.
21. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
22. Tabaton M., Nunzi M. G., Xue R., Usiak M., Autilio-Gambetti L., and Gambetti P. (1994) Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem. Riophys. Res. Commun. 200, 1598-1603.
23. Tierney M. C., Fisher R. H., Lewis A. J., Zorzitto M. L., Snow W. G., Reid D. W., and Nieuwstraten P. (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38, 359-364.
24. van Gool W. A., Schenk D. B., and Bolhuis P. A. (1994) Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett. 172, 122-124.
25. Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., and Schenk D. B. (1993) Characterization of β-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968.
26. Wang R., Sevier E. D., Reisfeld R. A., and David G. S. (1977) Semi-automatic solid-phase radioimmunoassay for carcinoembryonic antigen. J. Immunol. Methods 18, 157-164.